The General Hospital Corporation;Dana-Farber Cancer Institute, Inc.
发明人:
Kai W. Wucherpfennig,Glenn Dranoff,Penghui Zhou,Donald Shaffer,Nir Hacohen,Harvey I. Cantor,Diana Alvarez Arias
申请号：
US14897210
公开号：
US09944931B2
申请日:
2014.06.10
申请国别(地区):
US
年份:
2018
代理人:
摘要：
The present disclosure provides, in part, methods of discovering immunotherapy targets in vivo, therapeutic compositions (e.g., shRNA, immunoresponsive cells expressing shRNA and/or a chimeric antigen receptors (CAR)), and methods of use thereof.
